Skip to main content Skip to navigation Skip to mobile navigation Skip to accessibility tools

Switchboard0151 556 5000

24/7 hotline (treatment side-effects)
The Clatterbridge Cancer Centre NHS Foundation Trust

You can search our website using your chosen language.

Private care
Charity
  • Home
  • Patients and visitors
    • Patients and visitors
    • Treatment and care
      • Treatment and care
      • Treatments
      • Cancer types
      • Consultants
      • Your first visit
      • Hospital appointments
      • Video appointments
      • Inpatients
      • Health advice - eating well, exercise and cancer care
        • Health advice - eating well, exercise and cancer care
        • Physical activity and cancer care
        • Eating well and cancer care
      • Clinical trials
      • Visitors
      • Getting here
      • Isle of Man patients
      • Private and international patients
      • Advice and support
        • Advice and support
        • Arts programme
        • Benefits advice
        • Bereavement support and advice
        • Cancer information and support centres
        • Chaplaincy
        • Interpreters and help with additional needs
        • LGBTQ+ Patients
      • Feedback, compliments and complaints
      • Patient portal
        • Patient portal
        • Your hospital letters and appointment details – Healthcare Communications portal
        • Your health record, care plan and other information – our Patients Know Best portal
      • Patient information leaflets
        • Patient information leaflets
        • Lung cancer nursing team
        • Radiotherapy
        • Contact x-ray brachytherapy for rectal cancer (Papillon)
        • You and your gastrostomy feeding tube
        • Insertion of a rectal spacer for radiotherapy
        • High Dose Rate (HDR) brachytherapy to the vaginal vault
        • Proton beam therapy to the eye
        • High Dose Rate (HDR) brachytherapy to the skin
        • High Dose Rate (HDR) brachytherapy for cancer of the cervix
        • Treatment of prostate cancer with high dose rate (HDR) brachytherapy
        • Treatment of prostate cancer with high dose rate (HDR) brachytherapy in combination with external beam radiotherapy (EBRT)
        • Immunotherapy
        • Nasogastric tube - Being discharged with a nasogastric tube
        • You and your Totally Implanted Vascular Access Device (TIVAD) - Portacath
        • You and your PICC line
        • Eating well and coping well with side-effects on a vegan diet
        • Low residue diet information
        • Adding extra nourishment to your food when you have diabetes
        • Eating well and coping with side-effects
        • Proton beam therapy: Frequently asked questions and other useful information
        • Hepato-pancreato-biliary (HPB) nursing and support team
        • Arthralgia
        • Immune-related hepatitis
        • Skin care advice for patients on immunotherapy treatment
        • Infliximab - frequently asked questions
        • Cancer of Unknown Primary
        • Your nasogastric (NG) feeding tube and medication
        • Lymphoedema advice
        • What to do after an extravasation
        • Scalp cooling - a guide for patients
        • Breast cancer nursing team
        • Prostate / Bladder Cancer Nursing and Support Team
        • Skin cancer nursing team
        • Upper gastrointestinal (UGI) nursing and support team
        • Teenage and Young Adult service
        • Choosing a wig
        • Your cancer treatment in your community
        • Liver surveillance service
        • Supported self management and patient-directed open access - MGUS
        • Sick day rules for people on basal bolus or pre-mixed insulin
        • Patient information for referral for consideration of SABR
        • Advice to patients with a cardiac implantable electronic device – pacemakers or ICDS
        • How can we help? (Holistic Needs Assessment)
        • Pituitary and craniopharyngioma – radiotherapy
        • My Medical Record - information for patients
        • Lenalidomide (Revlimid) switch to generic equivalents
        • Lidocaine 2% mouthwash
        • Driving and diabetes
        • Hypos (hypoglycaemia)
        • Sick day rules for people on once-daily long-acting insulin
        • Safe sharps disposal
        • Information for people with Type 2 diabetes commencing steroids
        • What are ketones?
        • Chemotherapy group pre-assessment sessions
        • Etoposide
        • Temozolomide
        • Procarbazine
        • Lomustine (CCNU)
        • Temozolomide with Radiotherapy
        • Hospital water safety
        • Going home after your Stem Cell Transplant
        • Going home after CAR-T therapy
      • Request your records (subject access requests)
        • Request your records (subject access requests)
        • Request your records - easy-read information
        • Subject Access Request Form
      • Referral and second opinion
      • Hospital letters and communication with patients
    • Our hospitals
    • Our services
    • Consultants
    • Get involved
  • Research and innovation
    • Research and innovation
    • Research
      • Research
      • Welcome to research
      • Our research
        • Our research
        • Performance reports in initiating and delivering research
      • Research sponsorship
      • Clinical trials
      • Find a clinical trial or research study
      • Meet the team
      • Research partnerships
      • Jargon buster
      • Biobank
      • Research Strategy
      • Research: How you can get involved
      • Research passports, honorary research contracts and letters of access
      • Research news
      • Research achievements and publications
    • Innovation
      • Innovation
      • Welcome to innovation
      • Collaborative partnerships
  • Work with us
    • Work with us
    • Vacancies
    • Joining our team
    • Your career: Our recruitment pack
    • Staff benefits: why choose us
      • Staff benefits: why choose us
      • Staff networks
      • Staff Excellence Awards 2024
        • Staff Excellence Awards 2024
        • Staff Excellence Awards 2024 Event Brochure
      • Staff Excellence Awards 2025
    • Roles and careers we offer
      • Roles and careers we offer
      • Radiography
        • Radiography
        • Diagnostic radiography careers with us
        • Therapeutic radiography careers with us
      • Healthcare science
      • Physiotherapy
    • Staff profiles
    • Staff bank
    • Living locally
    • Apprenticeships
    • Volunteering
    • Get involved
    • Staff privacy notice
  • Professionals
    • Professionals
    • Education and training
      • Education and training
      • Clinical education courses
      • Clinical scientist training
      • Communication skills
      • FRCR Part 2b mock exam
      • Nursing career pathway
        • Nursing career pathway
        • Nursing career pathway and competency framework toolkit
      • Papillon
      • Medical education and training
    • Clinical guidance
      • Clinical guidance
      • Acute oncology (AO) and CUP guidance
      • Immunotherapy guidance
      • Metastatic spinal cord compression (MSCC) guidance
      • Catheter and line care guidance
      • SACT protocols and guidance
        • SACT protocols and guidance
        • All protocols and guidance
        • Breast
        • CNS
        • Gastrointestinal
        • Germ cell
        • Gynaecological
        • Haematology
        • Head and neck
        • Lung
        • Miscellaneous
        • Renal
        • Sarcoma
        • Skin
        • Supportive therapies
        • Urology
      • Referring patients
        • Referring patients
        • CT referral guidance
        • Interventional radiology referral guidance
        • MRI referral guidance
        • Nuclear medicine referral guidance
        • PET-CT referral guidance
        • Ultrasound referral guidance
        • X-ray referral guidance
      • Haemato-Oncology (haematology) clinical guidance
    • Work with us
  • About us
    • About us
    • Who we are
    • Vision and strategy
      • Vision and strategy
      • Vision, mission and values
      • Our strategy 2025 and beyond
      • Other strategies and plans
        • Other strategies and plans
        • Digital Strategy
        • Green Plan
        • Innovation Strategy
        • Patient Experience Commitment
        • People Commitment
        • Quality Improvement and Learning Strategy
        • Research Strategy
        • Transforming Cancer Care: What we achieved and lessons learned
    • How we're run
      • How we're run
      • Trust Board
        • Trust Board
        • Trust Board meetings and papers
      • Procurement
      • Council of Governors
        • Council of Governors
        • Our governors
      • Membership of our Trust
    • Who we work with
    • How we're doing
      • How we're doing
      • Our reports and accounts
      • Care Quality Commission
      • Equality, diversity and inclusion
      • Achievements and accreditations
      • Safe staffing
    • Our services
    • Our history
    • Publications and documents
    • Freedom of Information (FOI)
    • News
    • Get involved
    • C3 Magazine
  • Contact us
  • Clatterbridge Cancer Centre on Facebook
  • Clatterbridge Cancer Centre on Instagram
  • Clatterbridge Cancer Centre on X
  • Clatterbridge Cancer Centre on Youtube
  • Clatterbridge Cancer Centre on LinkedIn

Lung

You are here:

  1. Home
  2. Professionals
  3. Clinical guidance
  4. SACT protocols and guidance
  5. Lung

On this page…

Thumbnail Title
PDF file icon Adjuvant Osimertinib
PDF file icon Afatinib Non Small Cell Lung Cancer Protocol
PDF file icon Alectinib V1.2
PDF file icon ATEZOLIZUMAB AND BEVACIZUMAB FOC
PDF file icon Atezolizumab For Urinary tract squamous cell carcinoma (Compassionate use)
PDF file icon Atezolizumab NSCLC
PDF file icon Atezolizumab Urothelial Carcinoma Transitional Cell Carcinoma
PDF file icon Atezolizumab, Bevacizumab, Paclitaxel & Carboplatin Non-Small Cell Lung (NSCLC)
PDF file icon Atezolizumab, Carboplatin and Etoposide (Oral and IV regimens) Small Cell Lung Cancer (SCLC)
PDF file icon Bevacizumab FOC Advanced MPM protocol
PDF file icon Brigatinib 1.3
PDF file icon Carboplatin & Pemetrexed Non-Small Cell Lung Cancer and Malignant Mesothelioma Protocol
PDF file icon Carboplatin & Vinorelbine Non Small Cell Lung Cancer Protocol V1.0
PDF file icon Carboplatin Etoposide (Oral and IV regimens) Small Cell Carcinoma
PDF file icon Carboplatin with Paclitaxel and Pembrolizumab
PDF file icon Carboplatin with Pemetrexed and Pembrolizumab v1.3
PDF file icon Ceritinib Non Small Cell Lung Cancer Protocol V2.1
PDF file icon Cisplatin - Etoposide Concurrent or Sequential with ONCE Daily Radiotherapy (RT) Limited Stage SCLC
PDF file icon Cisplatin & Gemcitabine Non Small Cell Lung Cancer Protocol V1.0
PDF file icon Cisplatin & Pemetrexed Non-Small Cell Lung Cancer and Malignant Mesothelioma Protocol
  • ← Previous page
  • Page 1
  • Page 2
  • Page 3
  • Next page→

More in this section...

All protocols and guidance

Breast

CNS

Gastrointestinal

Germ cell

Gynaecological

Haematology

Head and neck

Miscellaneous

Renal

Sarcoma

Skin

Supportive therapies

Urology

Last updated 8th April 2024

  • Aintree
    Telephone: 0151 556 5958
  • Liverpool
    Telephone: 0151 556 5000
  • Wirral
    Telephone: 0151 556 5000
  • Other clinics
    Telephone: 0151 556 5000
  • Paddington
    Telephone: 0151 556 5000
  • Clatterbridge Cancer Centre on Facebook
  • Clatterbridge Cancer Centre on Instagram
  • Clatterbridge Cancer Centre on X
  • Clatterbridge Cancer Centre on Youtube
  • Clatterbridge Cancer Centre on LinkedIn
  • Compliments and complaints
  • Vacancies
  • Accessibility statement
  • Privacy
  • Freedom of information
  • CQC rating

Accessibility tools

Text size:
Contrast:

Created by Frank Ltd.

Return to header
Last accessibility toolbar action: none available